Wockhardt, one of the leading pharmaceutical and biotechnology company, witnessed a rise in share price on Tuesday after the UK health regulator, Medicines and Healthcare Products Regulatory Agency (MHRA) completed inspection of Chikalthana manufacturing facility.

The drug maker said, "MHRA inspected the plant at Chikalthana in Maharashtra. The UK health regulator did not issue any critical observations on the facility."

Shares of Wockhardt are trading at Rs 1,584.00, up Rs 42.85, or 2.78% at the Bombay Stock Exchange (BSE) on Tuesday at 12:21 p.m.

Total volume of shares traded on the bourses today was lower by 46.15% to 1,110,007 compared with 22-day average volume of 2,061,242.